151 related articles for article (PubMed ID: 25579735)
1. Plasmapheresis in renal diseases: personal experience.
Cavoli GL; Bono L; Tortorici C; Ferrantelli A; Giammarresi C; Rotolo U
Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):137-8. PubMed ID: 25579735
[No Abstract] [Full Text] [Related]
2. [Role of plasmapheresis in immunological kidney diseases. Experience from 1050 completed plasmapheresis treatment sessions].
Haris A; Arányi J; Braunitzer H; Kálmán E; Merán Z; Soltész M; Polner K
Orv Hetil; 2011 Jul; 152(28):1110-9. PubMed ID: 21712172
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic plasmapheresis using membrane plasma separation.
Sinha A; Tiwari AN; Chanchlani R; Seetharamanjaneyulu V; Hari P; Bagga A
Indian J Pediatr; 2012 Aug; 79(8):1084-6. PubMed ID: 22766901
[TBL] [Abstract][Full Text] [Related]
4. Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse.
Yamaguchi M; Ando M; Kato S; Katsuno T; Kato N; Kosugi T; Sato W; Tsuboi N; Yasuda Y; Mizuno M; Ito Y; Matsuo S; Maruyama S
J Rheumatol; 2015 Oct; 42(10):1853-60. PubMed ID: 26373560
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary renal vasculitis syndromes.
Lee RW; D'Cruz DP
Autoimmun Rev; 2010 Aug; 9(10):657-60. PubMed ID: 20472100
[TBL] [Abstract][Full Text] [Related]
6. Plasmapheresis therapy in ANCA-associated vasculitides: A single-center retrospective analysis of renal outcome and mortality.
Solar-Cafaggi D; Atisha-Fregoso Y; Hinojosa-Azaola A
J Clin Apher; 2016 Oct; 31(5):411-8. PubMed ID: 26194633
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic plasmapheresis. Possible indications].
Nielsen LP
Ugeskr Laeger; 1983 Apr; 145(14):1041-7. PubMed ID: 6683438
[No Abstract] [Full Text] [Related]
8. Plasmapheresis rescue therapy in progressive systemic ANCA-associated vasculitis: single-center results of stepwise escalation of immunosuppression.
de Joode AA; Sanders JS; Smid WM; Stegeman CA
J Clin Apher; 2014 Oct; 29(5):266-72. PubMed ID: 24497412
[TBL] [Abstract][Full Text] [Related]
9. Rapid progression to end-stage renal disease in a young female with mixed immunopathological features of lupus and ANCA-associated vasculitis.
Fukue R; Takeno M; Miyamoto D; Shirai Y; Nagahama K; Shimizu A; Kuwana M
Int J Rheum Dis; 2019 May; 22(5):956-958. PubMed ID: 30968562
[No Abstract] [Full Text] [Related]
10. Recovery of Kidney Function Among Patients With Glomerular Disease Starting Maintenance Dialysis.
Kwong YD; Liu KD; Hsu RK; Johansen KL; McCulloch CE; Seth D; Fallahzadeh MK; Grimes BA; Ku E
Am J Kidney Dis; 2021 Feb; 77(2):303-305. PubMed ID: 32771649
[No Abstract] [Full Text] [Related]
11. Recent advances in immunological therapy: plasma-exchange and immunosuppression.
Pinching AJ
Br J Anaesth; 1979 Jan; 51(1):21-8. PubMed ID: 162204
[No Abstract] [Full Text] [Related]
12. Plasma exchange in the treatment of glomerulonephritis and other renal diseases.
Walker RG; Becker GJ; d'Apice AJ; Kincaid-Smith P
Aust N Z J Med; 1986 Dec; 16(6):828-38. PubMed ID: 3551905
[No Abstract] [Full Text] [Related]
13. [Recent advances in the treatment of antineutrophil cytoplasm antibody associated vasculitides].
Szabó MZ; Pálfi P; Bazsó A; Poór G; Kiss E
Orv Hetil; 2015 Oct; 156(41):1653-60. PubMed ID: 26551168
[TBL] [Abstract][Full Text] [Related]
14. Extracapillary glomerulonephritis type I with the coexistence of positive anti-GBM and p-ANCA antibodies.
Toledo Perdomo K; Ortega Salas R; Pérez-Sáez MJ; Esquivias de Motta E; Espinosa Hernández M; López Andreu M; López Rubio F; Aljama García P
Nefrologia; 2011; 31(1):113-5. PubMed ID: 21270926
[No Abstract] [Full Text] [Related]
15. Pauci-immune necrotizing glomerulonephritis.
Rutgers A; Sanders JS; Stegeman CA; Kallenberg CG
Rheum Dis Clin North Am; 2010 Aug; 36(3):559-72. PubMed ID: 20688250
[TBL] [Abstract][Full Text] [Related]
16. [Differential diagnosis and therapy of pulmorenal syndrome--the nephrologist's perspective].
Böger CA; Banas B; Krämer BK
Dtsch Med Wochenschr; 2007 Sep; 132(36):1842-7. PubMed ID: 17726658
[TBL] [Abstract][Full Text] [Related]
17. The treatment of ANCA-associated rapidly-progressive glomerulonephritis and Goodpasture syndrome with therapeutic apheresis.
Apaydin S
Transfus Apher Sci; 2018 Feb; 57(1):8-12. PubMed ID: 29503131
[TBL] [Abstract][Full Text] [Related]
18. Plasmapheresis in the treatment of glomerulonephritis: indications and complications.
Sanz-Guajardo D
Am J Kidney Dis; 2000 Aug; 36(2):liv-lvi. PubMed ID: 10970237
[No Abstract] [Full Text] [Related]
19. Plasmapheresis. Technical aspects and indications.
Madore F
Crit Care Clin; 2002 Apr; 18(2):375-92. PubMed ID: 12053839
[TBL] [Abstract][Full Text] [Related]
20. Outcome of collagen vascular diseases by treatment with plasmapheresis.
Hashimoto H; Yano T; Kawanishi T; Tsuda H; Nagasawa T
Ther Apher; 1998 Nov; 2(4):268-72. PubMed ID: 10227753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
